Abbott restarts Similac infant formula production at Sturgis plant after six-month shutdown
date:Aug 30, 2022
ological testing throughout the manufacturing process, and that we would never release products that dont meet our quality and safety standards, Abbott notes.

The company underscores that it will have supplied the US with 8 million pounds of infant formula in August, which is above what we produced in August 2021.

Even though Abbott voluntarily recalled its products, the FDA allowed sales of the three formula types to continue to tackle the supply shortage.
7/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/21 03:46